Aclaris Therapeutics, Inc.

A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.

ACRS | NDAQ

Overview

Corporate Details

ISIN(s):: US00461U1051
LEI:
Country:: United States of America
Address:: 701 LEE ROAD, 19087 WAYNE
Website:: https://www.aclaristx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company aims to translate scientific discovery into therapeutic solutions for underserved conditions. Aclaris leverages its core expertise in drug discovery, development, and kinase inhibition to advance a pipeline of innovative small and large molecule drugs designed to address significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Aclaris Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aclaris Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Aclaris Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Genomictree Inc. Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.	South Korea	228760
Genomtec S.A. Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.	Poland	GMT
GENOTECH CORP. A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.	South Korea	066830
Genprex, Inc. A clinical-stage firm developing non-viral gene therapies for cancer and diabetes.	United States of America	GNPX
Gentian Diagnostics ASA Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.	Norway	GENT
GERON CORP Commercializes an approved, first-in-class telomerase inhibitor for blood cancers.	United States of America	GERN
GH Research PLC Clinical-stage biopharma developing mebufotenin therapies for psychiatric disorders.	United States of America	GHRS
GI Innovation Inc. Develops fusion protein biologics for oncology, allergic, and metabolic diseases.	South Korea	358570
GILEAD SCIENCES, INC. Develops innovative medicines for life-threatening diseases in virology, oncology & inflammation.	United States of America	GILD
GlaxoSmithKline PLC A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.	United Kingdom	GSK